Cancer BiologybioRxivPreprint
An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive breast cancer
Kenichi Shimada, Daniel E. Michaud, Yvonne Xiaoyong Cui…·Jennifer L. Guerriero
This study identifies an estrogen receptor signaling program in HR+ breast cancer that suppresses immune responses by reducing T cell infiltration and HLA expression, suggesting therapeutic targets to enhance immunogenicity.
5 citations